Research

Items by Godage, Himali

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 10.

Wang, H., Godage, H. Y., Riley, A. M., Weaver, J. D., Shears, S. B. and Potter, B. V. L., 2014. Synthetic inositol phosphate analogs reveal that PPIP5K2 has a surface-mounted substrate capture site that is a target for drug discovery. Chemistry & Biology, 21 (5), pp. 689-699.

Veiga, N., Torres, J., Macho, I., Gómez, K., Godage, H.Y., Riley, A.M., Potter, B.V.L., González, G. and Kremer, C., 2013. Inframolecular acid-base and coordination properties towards Na+ and Mg2+ of myo-inositol 1,3,4,5,6-pentakisphosphate : A structural approach to biologically relevant species. Dalton Transactions, 42 (17), pp. 6021-6032.

Godage, H. Y., Riley, A. M., Woodman, T. J., Thomas, M. P., Mahon, M. F. and Potter, B. V. L., 2013. Regioselective opening of myo-inositol orthoesters : Mechanism and synthetic utility. Journal of Organic Chemistry, 78 (6), pp. 2275-2288.

Turner, B. L., Cheesman, A. W., Godage, H. Y., Riley, A. M. and Potter, B. V. L., 2012. Determination of neo-and D-chiro-inositol hexakisphosphate in soils by solution 31P NMR spectroscopy. Environmental Science & Technology, 46 (9), pp. 4994-5002.

Falasca, M., Riley, A., Godage, H. and Potter, B., 2011. Novel Inositol Phosphate Derivatives. A61K31/661-WO2011064559 (A2), 03 June 2011.

Falasca, M., Chiozzotto, D., Godage, H. Y., Mazzoletti, M., Riley, A. M., Previdi, S., Potter, B. V. L., Broggini, M. and Maffucci, T., 2010. A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. British Journal of Cancer, 102 (1), pp. 104-114.

Veiga, N., Torres, J., Godage, H. Y., Riley, A. M., Dominguez, S., Potter, B. V. L., Diaz, A. and Kremer, C., 2009. The behaviour of inositol 1,3,4,5,6-pentakisphosphate in the presence of the major biological metal cations. Journal of Biological Inorganic Chemistry, 14 (7), pp. 1001-1013.

Riley, A. M., Godage, H. Y., Mahon, M. F. and Potter, B. V. L., 2006. Chiral desymmetrisation of myo -inositol 1,3,5-orthobenzoate gives rapid access to precursors for second messenger analogues. Tetrahedron: Asymmetry, 17, pp. 171-174.

Godage, H. Y., Riley, A. M., Woodman, T. J. and Potter, B. V. L., 2006. Regioselective hydrolysis of myo-inositol 1,3,5-orthobenzoate via a 1,2-bridged 2'-phenyl-1,3'-dioxolan-2'-ylium ion provides a rapid route to the anticancer agent Ins(1,3,4,5,6,)P5. Chemical Communications, 2006 (28), pp. 2989-2991.

Maffucci, T., Piccolo, E., Cumashi, A., Lezzi, M., Riley, A. M., Saiardi, A., Godage, H. Y., Rossi, C., Broggini, M., Iacobelli, S., Potter, B. V. L., Innocenti, P. and Falasca, M., 2005. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Research, 65 (18), pp. 8339-8349.

This list was generated on Mon Oct 20 09:16:28 2014 IST.